1. Home
  2. IMNM vs ATS Comparison

IMNM vs ATS Comparison

Compare IMNM & ATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$18.07

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$28.24

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
ATS
Founded
2006
1978
Country
United States
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
IMNM
ATS
Price
$18.07
$28.24
Analyst Decision
Strong Buy
Hold
Analyst Count
10
1
Target Price
$32.80
$35.00
AVG Volume (30 Days)
1.2M
174.2K
Earning Date
05-08-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
51.40
N/A
EPS
N/A
N/A
Revenue
$6,941,000.00
N/A
Revenue This Year
N/A
$17.99
Revenue Next Year
$1,127.34
$4.52
P/E Ratio
N/A
$222.92
Revenue Growth
N/A
N/A
52 Week Low
$7.96
$23.85
52 Week High
$27.65
$35.82

Technical Indicators

Market Signals
Indicator
IMNM
ATS
Relative Strength Index (RSI) 33.00 42.73
Support Level $16.81 $26.39
Resistance Level $19.16 $30.52
Average True Range (ATR) 0.92 1.44
MACD -0.21 -0.26
Stochastic Oscillator 1.24 22.69

Price Performance

Historical Comparison
IMNM
ATS

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

Share on Social Networks: